Metsera

Metsera Graham Number

Delisted

The Graham Number of Metsera (MTSR) as of Nov 22, 2026 is 11.26 USD. In the previous year, Graham Number was 6.37 USD — a change of 76.72% (higher).

Graham Number

11.26USD

YoY

76.72%

Last updated:

Graham Number of Metsera is 2024 11.26 USD. Graham Number of Metsera was 2023 6.37 USD. It decreases by 76.72% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Graham Number of Metsera is 11.26 USD in 2024.

On Eulerpool you can find the complete historical development of Graham Number Metsera since 2006 – with annual values, charts, and detailed analysis.

The Graham Number estimates the maximum fair price for a stock based on EPS and book value per share, following Benjamin Graham's value investing principles.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Metsera

All Key Metrics — Metsera